Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chuanxiong Chatiao San is a classic Traditional Chinese Medicine (TCM) formula widely used for the treatment of headaches, including migraines, tension-type headaches, and those associated with the common cold (wind-cold or wind-heat patterns). The formula's name translates to "Chuanxiong Tea-Adjusted Powder," as it is traditionally administered with green tea to enhance its cooling and descending properties. Its primary active ingredient, *Ligusticum chuanxiong*, contains bioactive compounds such as ligustilide and ferulic acid, which possess analgesic, anti-inflammatory, and vasodilatory effects. The formula is thought to alleviate pain by modulating neurotransmitter levels (particularly serotonin), inhibiting inflammatory mediators like prostaglandins, and improving cerebral microcirculation. It is officially recognized in the Chinese Pharmacopoeia and is available in various formulations including powders, pills, and granules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chuanxiongchatiaosan.